Corpus Intelligence IC Memo — SENTARA VA. BEACH GENERAL HOSPITAL 2026-04-26 06:41 UTC
IC Memo — SENTARA VA. BEACH GENERAL HOSPITAL
Investment Committee Memorandum | VA | 239 beds | Grade B | EBITDA uplift $32.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SENTARA VA. BEACH GENERAL HOSPITAL

CCN 490057 | VIRGINIA BEACH CITY, VA | 239 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SENTARA VA. BEACH GENERAL HOSPITAL is a 239-bed suburban community hospital in VIRGINIA BEACH CITY, VA with $443.9M in net patient revenue and a 15.2% operating margin. The hospital serves a payer mix of 40.7% Medicare, 3.3% Medicaid, and 56.0% commercial.

Thesis: Platform Growth. Our ML models identify $32.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.2% to 22.6% (+736bps).

Net Revenue HCRIS$443.9M
Current EBITDA COMPUTED$67.7M
Operating Margin COMPUTED15.2%
Occupancy HCRIS80.5%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS26.3%
Distress Probability ML40.6%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
32
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 15.2% places it above the state median. Among 32 size-comparable peers (120-478 beds), the median margin is 4.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (120-478), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SENTARA VA. BEACH GENERAL HOSP (Target)VA239$443.9M15.2%
SENTARA NORFOLK GENERAL HOSPITVA472$1.34B4.9%
RIVERSIDE REGIONAL MEDICAL CENVA379$963.3M-20.1%
WINCHESTER MEDICAL CENTERVA455$694.7M-5.8%
ST. MARYS HOSPITALVA363$688.9M13.3%
VIRGINIA HOSPITAL CENTER ARLINVA336$624.4M1.8%
MARY WASHINGTON HOSPITALVA440$552.1M1.7%
CHILDRENS HOSPITAL OF THE KINGVA202$546.2M-9.9%
SENTARA LEIGH HOSPITALVA274$511.5M14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $32.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.3M+210bp18mo
Cost to Collect4.5%2.5%$8.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$8.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.4M+122bp9mo
Clean Claim Rate88.0%96.0%$284K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.3M
Cost to Collect
$8.9M
Denial Rate Reduction
$8.8M
A/R Days Reduction
$5.4M
Clean Claim Rate
$284K
Total EBITDA Uplift$32.7M
Current EBITDA$67.7M
+ RCM Uplift+$32.7M
Pro Forma EBITDA$100.4M
Current Margin15.2%
Pro Forma Margin22.6%
WC Released (1x)$17.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$104.1M$773.2M7.43x49.3%
Base (11x exit)10.0x11.0x$104.1M$884.4M8.49x53.4%
Bull Case9.0x11.0x$93.7M$1.03B10.95x61.4%
Bull (12x exit)9.0x12.0x$93.7M$1.15B12.24x65.0%
Bear Case11.0x10.0x$114.5M$576.0M5.03x38.1%
Bear (11x exit)11.0x11.0x$114.5M$670.8M5.86x42.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 120-478 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-3.6% / P50=4.9% / P75=13.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.